Colgate

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Colgate 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CL

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care, and Pet Nutrition segments. 

CEO
Noel R. Wallace
CEONoel R. Wallace
Employees
33,600
Employees33,600
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1806
Founded1806
Employees
33,600
Employees33,600

CL Key Statistics

Market cap
71.20B
Market cap71.20B
Price-Earnings ratio
33.46
Price-Earnings ratio33.46
Dividend yield
2.36%
Dividend yield2.36%
Average volume
6.81M
Average volume6.81M
High today
$89.30
High today$89.30
Low today
$87.95
Low today$87.95
Open price
$89.17
Open price$89.17
Volume
5.71M
Volume5.71M
52 Week high
$99.33
52 Week high$99.33
52 Week low
$74.55
52 Week low$74.55

Stock Snapshot

With a market cap of 71.2B, Colgate(CL) trades at $88.50. The stock has a price-to-earnings ratio of 33.46 and currently yields dividends of 2.4%.

On 2026-03-13, Colgate(CL) stock moved within a range of $87.95 to $89.30. With shares now at $88.50, the stock is trading +0.6% above its intraday low and -0.9% below the session's peak.

Trading volume for Colgate(CL) stock has reached 5.71M, versus its average volume of 6.81M.

The stock's 52-week range extends from a low of $74.55 to a high of $99.33.

The stock's 52-week range extends from a low of $74.55 to a high of $99.33.

CL News

Simply Wall St 7h
Colgate-Palmolive Adds Healthcare CEO To Board And Extends Dividend Streak

Colgate-Palmolive (NYSE:CL) appointed Christopher Boerner, CEO of Bristol-Myers Squibb, to its Board of Directors. Board member Steven Cahillane will not stand...

Colgate-Palmolive Adds Healthcare CEO To Board And Extends Dividend Streak
TipRanks 1d
Colgate-Palmolive Refreshes Board With New Bristol Myers Leader

The latest update is out from Colgate-Palmolive ( (CL) ). On March 12, 2026, Colgate-Palmolive’s board elected Christopher S. Boerner, Board Chair and Chief Ex...

TipRanks 1d
Colgate-Palmolive raises quarterly dividend to 53c per share from 52c

The Board of Directors of Colgate-Palmolive (CL) Company announced an increase in the quarterly common stock cash dividend to $0.53 up from $0.52 per share. The...

Analyst ratings

52%

of 23 ratings
Buy
52.2%
Hold
43.5%
Sell
4.3%

More CL News

TipRanks 1d
Colgate-Palmolive names Bristol-Myers CEO Boerner to board

Colgate-Palmolive (CL) announced that Christopher Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company (BMY), has been electe...

Simply Wall St 2d
Colgate-Palmolive Valuation Check After Recent Share Price Pullback

Colgate-Palmolive (CL) is back on many investors’ screens after recent share price moves, including a roughly 3% decline over the past week and a 5% pullback ov...

Colgate-Palmolive Valuation Check After Recent Share Price Pullback
Simply Wall St 4d
Is Colgate-Palmolive Pricing Look Attractive After Mixed Short-Term Returns?

If you are wondering whether Colgate-Palmolive is fairly priced at around US$93 a share, you are not alone. Many investors are asking the same question about wh...

Is Colgate-Palmolive Pricing Look Attractive After Mixed Short-Term Returns?

People also own

Based on the portfolios of people who own CL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.